Drug Profile
Recombinant granulocyte macrophage colony stimulating factor - Profarma
Alternative Names: PF-11Latest Information Update: 28 Jul 2019
Price :
$50
*
At a glance
- Originator Profarma
- Class Adjuvants; Glycoproteins; Granulocyte-macrophage colony-stimulating factors
- Mechanism of Action Granulocyte-macrophage colony stimulating factor replacements; Haematopoiesis stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cancer; Haematological disorders
Most Recent Events
- 28 Jul 2019 No recent reports of development identified for research development in Cancer in Lithuania (Parenteral)
- 28 Jul 2019 No recent reports of development identified for research development in Haematological-disorders in Lithuania (Parenteral)
- 16 Jun 2015 Early research in Cancer in Lithuania (Parenteral) (Profarma pipeline, June 2015)